Kumar Amarjeet, Sinha Chandni, Singh Kunal, Anant Monika, Kumar Ajeet, Kumari Poonam
Department of Anaesthesiology, All India Institute of Medical Sciences, Patna, Bihar, India.
Department of Obstetrics and Gynaecology, All India Institute of Medical Sciences, Patna, Bihar, India.
Indian J Anaesth. 2024 Feb;68(2):159-164. doi: 10.4103/ija.ija_789_23. Epub 2024 Jan 29.
The incidence of post-dural puncture headache (PDPH) following spinal anaesthesia in the obstetric population is around 0.5%-2%. Hydration, bed rest, caffeine, paracetamol, non-steroid anti-inflammatory drugs, epidural blood patches, etc., are the various modalities used for its management. This study aims to compare nebulised dexmedetomidine versus fentanyl for the treatment of PDPH in parturients after caesarean section under spinal anaesthesia.
Ninety obstetric patients aged 18-35 years with American Society of Anesthesiologists (ASA) physical status II/III and suffering from PDPH as per the criteria of the International Headache Society after caesarean section under spinal anaesthesia were recruited in this double-blinded randomised study. Patients were randomised to Group D (dexmedetomidine 1 µg/kg nebulisation), Group F (fentanyl 1 µg/kg nebulisation), and Group S (saline nebulisation 4mL). The nebulisation was done 12 hourly for 72 hours. Assessment parameters included pain score and the requirement of additional treatment such as paracetamol, caffeine, and epidural blood patch. Analysis of variance test was used for continuous quantitative variables, and the Kruskal-Wallis test was used for quantitative discrete data.
The pain scores at 1, 6, 12, 24, 48, and 72 hours following nebulisation were significantly lower in Group D in comparison to groups F and S ( < 0.001). The number of patients requiring additional analgesic therapy was lower in Group D in comparison to patients in other groups ( < 0.001).
Dexmedetomidine nebulisation resulted in effective reduction in PDPH symptoms and pain scores. Nebulisation with fentanyl did not alleviate PDPH symptoms when compared to the control group.
产科人群中脊髓麻醉后发生硬膜穿刺后头痛(PDPH)的发生率约为0.5%-2%。补液、卧床休息、咖啡因、对乙酰氨基酚、非甾体类抗炎药、硬膜外血贴等是用于其治疗的各种方式。本研究旨在比较雾化右美托咪定与芬太尼用于治疗脊髓麻醉下剖宫产术后产妇PDPH的效果。
本双盲随机研究纳入了90例年龄在18-35岁、美国麻醉医师协会(ASA)身体状况分级为II/III级且在脊髓麻醉下行剖宫产术后符合国际头痛协会标准的PDPH产妇。患者被随机分为D组(雾化右美托咪定1μg/kg)、F组(雾化芬太尼1μg/kg)和S组(雾化生理盐水4mL)。每12小时雾化一次,共72小时。评估参数包括疼痛评分以及对额外治疗(如对乙酰氨基酚、咖啡因和硬膜外血贴)的需求。方差分析用于连续定量变量,Kruskal-Wallis检验用于定量离散数据。
与F组和S组相比,D组雾化后1、6、12、24、48和72小时的疼痛评分显著更低(<0.001)。与其他组患者相比,D组中需要额外镇痛治疗的患者数量更少(<0.001)。
雾化右美托咪定可有效减轻PDPH症状和疼痛评分。与对照组相比,雾化芬太尼未能缓解PDPH症状。